Is GHK-Cu Legal in Australia? A Research Perspective
How GHK-Cu sits under Australian regulation as a research compound, and what research-use-only supply means.
A general overview of how the copper-binding tripeptide GHK-Cu is positioned under Australian regulation as a research compound. General information for researchers, not legal or medical advice.
Research-use-only positioning
GHK-Cu is supplied in Australia strictly for in-vitro laboratory research — not for human or veterinary use, consumption, or therapeutic application. It is not an approved therapeutic good and is not marketed as a medicine.
What this means for a researcher
Australian researchers should ensure their intended use is genuinely research and complies with the laws and institutional rules that apply to them. A research-use-only label does not by itself exempt any compound from the Therapeutic Goods Act or relevant schedules.
- Not an approved therapeutic good
- Supplied for in-vitro research use only
- Not for human or veterinary use
- Researchers are responsible for their own compliance
GHK-Cu is stocked with a published COA for research use.
View GHK-CuFrequently asked questions
- Is GHK-Cu an approved medicine in Australia?
- No. It is not an approved therapeutic good; it is supplied strictly for in-vitro laboratory research use only.
- Can I order GHK-Cu for research in Australia?
- It is supplied to researchers and laboratories for in-vitro research use only, with a published Certificate of Analysis. You are responsible for ensuring your use complies with applicable law.
Related reading
GHK-Cu
What GHK-Cu (the copper tripeptide) is, why it is studied, and what to look for when sourcing it in Australia.
LegalityAre peptides legal in Australia?
A plain-English explainer on how research peptides are positioned in Australia and what "research use only" actually means.
HandlingHow to read a Certificate of Analysis
A short guide to what a Certificate of Analysis actually tells you — and what to check before you trust a vial.
Last updated 24 June 2026. This article is general information for researchers, not medical or legal advice.
